Platelet-derived growth factor BB mediates the glioma-induced migration of bone marrow-derived mesenchymal stem cells by promoting the expression of vascular cell adhesion molecule-1 through the PI3K, P38 MAPK and NF-κB pathways

Oncology Reports

Volumn 30, Issue 6, 2013, Pages 2755-2764

  Hu, Yi ^a   Cheng, Peng ^a   Jiang chun, Ma ^a   Xue, Yi ^a   Liu, Yun Hui ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Cell migration; Mesenchymal stem cells; Platelet derived growth factor; Vascular cell adhesion molecule 1

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR BB; RECOMBINANT PROTEIN; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER CELL CULTURE; CELL CULTURE; CELL ISOLATION; CELL MIGRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLIOMA; GLIOMA CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; MESENCHYMAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERODIAGNOSIS; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; BONE MARROW; CELL MOVEMENT; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; MESENCHYMAL STROMAL CELLS; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-SIS; RATS; SIGNAL TRANSDUCTION; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84892397715     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2780     Document Type: Article

References (43)

1. Kang SG, Shinojima N, Hossain A, Gumin J, Yong RL, Colman H, Marini F, Andreeff M and Lang FF: Isolation and perivascular localization of mesenchymal stem cells from mouse brain. Neurosurgery 67: 711-720, 2010.
2. Park D, Spencer JA, Koh BI, Kobayashi T, Fujisaki J, Clemens TL, Lin CP, Kronenberg HM and Scadden DT: Endogenous bone marrow MSCs are dynamic, fate-restricted participants in bone maintenance and regeneration. Cell Stem Cell 10: 259-272, 2012.
3. Crisan M, Yap S, Casteilla L, Chen CW, Corselli M, Park TS, Andriolo G, Sun B, Zheng B, Zhang L, Norotte C, Teng PN, Traas J, Schugar R, Deasy BM, Badylak S, Buhring HJ, Giacobino JP, Lazzari L, Huard J and Péault B: A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3: 301-313, 2008.
4. Pittenger M, Mackay A, Beck S, Jaiswal R, Douglas R, Mosca J, Moorman M, Simonetti D, Craig S and Marshak D: Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147, 1999.
5. Sotiropoulou PA, Perez SA, Gritzapis AD, Baxevanis CN and Papamichail M: Interactions between human mesenchymal stem cells and natural killer cells. Stem Cells 24: 74-85, 2006.
6. Li H, Guo Z, Jiang X, Zhu H, Li X and Mao N: Mesenchymal stem cells alter migratory property of T and dendritic cells to delay the development of murine lethal acute graft-versus-host disease. Stem Cells 26: 2531-2541, 2008.
7. Ho IA, Chan KY, Ng WH, Guo CM, Hui KM, Cheang P and Lam PY: Matrix metalloproteinase 1 is necessary for the migration of human bone marrow-derived mesenchymal stem cells toward human glioma. Stem Cells 27: 1366-1375, 2009.
8. Nakamura K, Ito Y, Kawano Y, Kurozumi K, Kobune M, Tsuda H, Bizen A, Honmou O, Niitsu Y and Hamada H: Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model. Gene Ther 11: 1155-1164, 2004.
9. Bexell D, Gunnarsson S, Tormin A, Darabi A, Gisselsson D, Roybon L, Scheding S and Bengzon J: Bone marrow multipotent mesenchymal stroma cells act as pericyte-like migratory vehicles in experimental gliomas. Mol Ther 17: 183-190, 2009.
10. Nakamizo A, Marini F, Amano T, Khan A, Studeny M, Gumin J, Chen J, Hentschel S, Vecil G, Dembinski J, Andreeff M and Lang FF: Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res 65: 3307-3318, 2005.
11. Yang B, Wu X, Mao Y, Bao W, Gao L, Zhou P, Xie R, Zhou L and Zhu J: Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-elated, apoptosis-inducing, ligand-engineered human mesenchymal stem cells. Neurosurgery 65: 610-624, 2009.
12. Uchibori R, Okada T, Ito T, Urabe M, Mizukami H, Kume A and Ozawa K: Retroviral vector producing mesenchymal stem cells for targeted suicide cancer gene therapy. J Gene Med 11: 373-381, 2009.
13. Matuskova M, Hlubinova K, Pastorakova A, Hunakova L, Altanerova V, Altaner C and Kucerova L: HSV-tk expressing mesenchymal stem cells exert bystander effect on human glioblastoma cells. Cancer Lett 290: 58-67, 2010.
14. Guo P, Hu B, Gu W, Xu L, Wang D, Huang HJS, Cavenee WK and Cheng SY: Platelet-derived growth factor-B enhances glioma angiogenesis by stimulating vascular endothelial growth factor expression in tumor endothelia and by promoting pericyte recruitment. Am J Pathol 162: 1083-1093, 2003.
15. Heldin CH and Westermark B: Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 79: 1283-1316, 1999.
16. Cheng P, Gao ZQ, Liu YH and Xue YX: Platelet-derived growth factor BB promotes the migration of bone marrow-derived mesenchymal stem cells towards C6 glioma and up-regulates the expression of intracellular adhesion molecule-1. Neurosci Lett 451: 52-56, 2009.
17. Hata N, Shinojima N, Gumin J, Yong R, Marini F, Andreeff M and Lang FF: Platelet-derived growth factor BB mediates the tropism of human mesenchymal stem cells for malignant gliomas. Neurosurgery 66: 144-156, 2010.
18. Engelhardt B: Molecular mechanisms involved in T cell migration across the blood-brain barrier. J Neural Transm 113: 477-485, 2006.
19. Mestre L, Iñigo PM, Mecha M, Correa FG, Hernangómez-Herrero M, Loría F, Docagne F, Borrell J and Guaza C: Anandamide inhibits Theiler's virus induced VCAM-1 in brain endothelial cells and reduces leukocyte transmigration in a model of blood brain barrier by activation of CB(1) receptors. J Neuroinflammation 8: 102 doi: 10.1186/1742-2094-8-102, 2011.
20. Hu Y, Cheng P, Xue YX and Liu YH: Glioma cells promote the expression of vascular cell adhesion molecule-1 on bone marrow-derived mesenchymal stem cells: a possible mechanism for their tropism toward gliomas. J Mol Neurosci 48: 127-135, 2012.
21. Segers VFM, Van Riet I, Andries LJ, Lemmens K, Demolder MJ, De Becker AJML, Kockx MM and De Keulenaer GW: Mesenchymal stem cell adhesion to cardiac microvascular endothelium: activators and mechanisms. American journal of physiology. Am J Physiol Heart Circ Physiol 290: H1370-H1377, 2006.
22. Seo J, Lee HS, Ryoo S, Seo JH, Min BS and Lee JH: Tangeretin, a citrus flavonoid, inhibits PGDF-BB-induced proliferation and migration of aortic smooth muscle cells by blocking AKT activation. Eur J Pharmacol 673: 56-64, 2011.
23. Chen HF, Xie LD and Xu CS: The signal transduction pathways of heat shock protein 27 phosphorylation in vascular smooth muscle cells. Mol Cell Biochem 333: 49-56, 2010.
24. Yoshimura H, Nariai Y, Terashima M, Mitani T and Tanigawa Y: Taurine suppresses platelet-derived growth factor (PDGF) BB-induced PDGF-β receptor phosphorylation by protein tyrosine phosphatase-mediated dephosphorylation in vascular smooth muscle cells. Biochim Biophys Acta 1745: 350-360, 2005.
25. Zheng L, Ishii Y, Tokunaga A, Hamashima T, Shen J, Zhao QL, Ishizawa S, Fujimori T, Nabeshima YI, Mori H, Kondo T and Sasahara M: Neuroprotective effects of PDGF against oxidative stress and the signaling pathway involved. J Neurosci Res 88: 1273-1284, 2010.
26. Romashkova JA and Makarov SS: NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. Nature 401: 86-90, 1999.
27. Birnbaum T, Roider J, Schankin CJ, Padovan CS, Schichor C, Goldbrunner R and Straube A: Malignant gliomas actively recruit bone marrow stromal cells by secreting angiogenic cytokines. J Neurooncol 83: 241-247, 2007.
28. Jiang B, Xu S, Hou X, Pimentel DR and Cohen RA: Angiotensin II differentially regulates interleukin-1-β-inducible NO synthase (iNOS) and vascular cell adhesion molecule-1 (VCAM-1) expression: role of p38 MAPK. J Biol Chem 279: 20363-20368, 2004.
29. Xiao Q, Wang S, Tian H, Xin L, Zou Z, Hu Y, Chang C, Wang X, Yin Q, Zhang X and Wang L: TNF-α increases bone marrow mesenchymal stem cell migration to ischemic tissues. Cell Biochem Biophys 62: 409-414, 2012.
30. Harting M, Jimenez F, Pati S, Baumgartner J and Cox C: Immunophenotype characterization of rat mesenchymal stromal cells. Cytotherapy 10: 243-253, 2008.
31. Westermark B, Heldin C-H and Nistér M: Platelet-derived growth factor in human glioma. Glia 15: 257-263, 1995.
32. Maher EA, Furnari FB, Bachoo RM, Rowitch DH, Louis DN, Cavenee WK and DePinho RA: Malignant glioma: genetics and biology of a grave matter. Genes Dev 15: 1311-1333, 2001.
33. Yilmaz G and Granger DN: Leukocyte recruitment and ischemic brain injury. Neuromolecular Med 12: 193-204, 2010.
34. Wang X, Feuerstein GZ, Gu JL, Lysko PG and Yue TL: Interleukin-1β induces expression of adhesion molecules in human vascular smooth muscle cells and enhances adhesion of leukocytes to smooth muscle cells. Atherosclerosis 115: 89-98, 1995.
35. Menon LG, Picinich S, Koneru R, Ggo H, Lin SY, Koneru M, Mayer-Kuchku P and Glod J: Differential gene expression associated with migration of mesenchymal stem cells to conditioned medium from tumor cells or bone marrow cells. Stem Cells 25: 520-528, 2007.
36. Ryu CH, Park SH, Park SA, Kim SM, Lim JY, Jeong CH, Yoon WS, Oh W, Sung YC and Jeun SS: Gene therapy of intracranial glioma using interleukin 12-secreting human umbilical cord blood-derived mesenchymal stem cells. Hum Gene Ther 22: 733-743, 2011.
37. Spaeth E, Klopp A, Dembinski J, Andreeff M and Marini F: Infl ammation and tumor microenvironments: defi ning the migratory itinerary of mesenchymal stem cells. Gene Ther 15: 730-738, 2008.
38. Schichor C, Birnbaum T, Etminan N, Schnell O, Grau S, Miebach S, Aboody K, Padovan C, Straube A, Tonn JC and Goldbrunner R: Vascular endothelial growth factor A contributes to glioma-induced migration of human marrow stromal cells (hMSC). Exp Neurol 199: 301-310, 2006.
39. Ponte ALL, Marais E, Gallay N, Langonne A, Delorme B, Herault O, Charbord P, Domenech J, Langonné A and Hérault O: The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells 25: 1737-1745, 2007.
40. Nazarenko I, Hede S-M, He X, Hedrén A, Thompson J, Lindström MS and Nistér M: PDGF and PDGF receptors in glioma. Ups J Med Sci 117: 99-112, 2012.
41. Jiang Y, Boije M, Westermark B and Uhrbom L: PDGF-B can sustain self-renewal and tumorigenicity of experimental glioma-derived cancer-initiating cells by preventing oligodendrocyte differentiation. Neoplasia 13: 492-503, 2011.
42. Tondreau T, Meuleman N, Stamatopoulos B, De Bruyn C, Delforge A, Dejeneffe M, Martiat P, Bron D and Lagneaux L: In vitro study of matrix metalloproteinase/tissue inhibitor of metalloproteinase production by mesenchymal stromal cells in response to inflammatory cytokines: the role of their migration in injured tissues. Cytotherapy 11: 559-569, 2009.
43. Hyun YM, Chung HL, McGrath JL, Waugh RE and Kim M: Activated integrin VLA-4 localizes to the lamellipodia and mediates T cell migration on VCAM-1. J Immunol 183: 359-369, 2009.